61 related articles for article (PubMed ID: 25742716)
1. Effects of growth hormone therapy on the onset and progression of pubertal development in girls with idiopathic short stature.
Zhu F; Xu Q; Huang L; Zhu J; Huang L; Zhang Y
Gynecol Endocrinol; 2024 Dec; 40(1):2358227. PubMed ID: 38807420
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of intestinal microbiota in children with idiopathic short stature: a cross-sectional study.
Miao J; Lai P; Wang K; Fang G; Li X; Zhang L; Jiang M; Bao Y
Eur J Pediatr; 2023 Oct; 182(10):4537-4546. PubMed ID: 37522979
[TBL] [Abstract][Full Text] [Related]
3. The Exon 3-Deleted Growth Hormone Receptor (d3GHR) Polymorphism-A Favorable Backdoor Mechanism for the GHR Function.
Falah G; Sharvit L; Atzmon G
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762211
[TBL] [Abstract][Full Text] [Related]
4. A Clinical Study on the Treatment of Children's Short Stature with Auxiliary Comprehensive Management Combined with Growth Patch.
Feng H; Zhao W; Yu H; Wang G; Wang Q
Evid Based Complement Alternat Med; 2021; 2021():7142006. PubMed ID: 34745298
[TBL] [Abstract][Full Text] [Related]
5. Role of
Parsons S; Stevens A; Whatmore A; Clayton PE; Murray PG
J Endocr Soc; 2022 Mar; 6(3):bvac006. PubMed ID: 35178492
[TBL] [Abstract][Full Text] [Related]
6. A 4-Year, Open-Label, Multicenter, Randomized Trial of Genotropin® Growth Hormone in Patients with Idiopathic Short Stature: Analysis of 4-Year Data Comparing Efficacy, Efficiency, and Safety between an Individualized, Target-Driven Regimen and Standard Dosing.
Counts DR; Silverman LA; Rajicic N; Geffner ME; Newfield RS; Thornton P; Carakushansky M; Escobar O; Rapaport R; Levitsky L; Rotenstein D; Hey-Hadavi J; Wajnrajch MP
Horm Res Paediatr; 2015; 84(2):79-87. PubMed ID: 25966824
[TBL] [Abstract][Full Text] [Related]
7. Recombinant Human Growth Hormone Therapy in Children with Chromosome 15q26 Deletion.
Ho SC; Clayton P; Vasudevan P; Greening J; Wardhaugh B; Shaw N; Kelnar C; Kirk J; Högler W
Horm Res Paediatr; 2015 Apr; ():. PubMed ID: 25924833
[TBL] [Abstract][Full Text] [Related]
8. Genetic and Epigenetic Modulation of Growth Hormone Sensitivity Studied With the IGF-1 Generation Test.
Ouni M; Castell AL; Linglart A; Bougnères P
J Clin Endocrinol Metab; 2015 Jun; 100(6):E919-25. PubMed ID: 25835289
[TBL] [Abstract][Full Text] [Related]
9. Growth Hormone Treatment Improves Cognitive Function in Short Children with Growth Hormone Deficiency.
Chaplin JE; Kriström B; Jonsson B; Tuvemo T; Albertsson-Wikland K
Horm Res Paediatr; 2015 Mar; ():. PubMed ID: 25823753
[TBL] [Abstract][Full Text] [Related]
10. Association between Growth Hormone-Insulin-Like Growth Factor-1 Axis Gene Polymorphisms and Short Stature in Chinese Children.
Zhang Y; Zhang M; Chu Y; Ji B; Shao Q; Ban B
Biomed Res Int; 2018; 2018():7431050. PubMed ID: 29687007
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone (GH) dose, but not exon 3-deleted/full-length GH receptor polymorphism genotypes, influences growth response to two-year GH Therapy in Short Small-for-Gestational-Age Children.
Carrascosa A; Audí L; Esteban C; Fernández-Cancio M; Andaluz P; Gussinyé M; Clemente M; Yeste D; Albisu MA
J Clin Endocrinol Metab; 2008 Jan; 93(1):147-53. PubMed ID: 17925340
[TBL] [Abstract][Full Text] [Related]
12. Impact of the exon 3-deleted growth hormone (GH) receptor polymorphism on baseline height and the growth response to recombinant human GH therapy in GH-deficient (GHD) and non-GHD children with short stature: a systematic review and meta-analysis.
Wassenaar MJ; Dekkers OM; Pereira AM; Wit JM; Smit JW; Biermasz NR; Romijn JA
J Clin Endocrinol Metab; 2009 Oct; 94(10):3721-30. PubMed ID: 19584188
[TBL] [Abstract][Full Text] [Related]
13. MECHANISMS IN ENDOCRINOLOGY: Clinical and pharmacogenetic aspects of the growth hormone receptor polymorphism.
Boguszewski CL; Barbosa EJL; Svensson PA; Johannsson G; Glad CAM
Eur J Endocrinol; 2017 Dec; 177(6):R309-R321. PubMed ID: 28904008
[TBL] [Abstract][Full Text] [Related]
14. The growth hormone receptor exon 3-deleted/full-length polymorphism and response to growth hormone therapy in prepubertal idiopathic short children.
Hellgren G; Glad CA; Jonsson B; Johannsson G; Albertsson-Wikland K
Growth Horm IGF Res; 2015 Jun; 25(3):127-35. PubMed ID: 25742716
[TBL] [Abstract][Full Text] [Related]
15. The exon 3-deleted/full-length growth hormone receptor polymorphism did not influence growth response to growth hormone therapy over two years in prepubertal short children born at term with adequate weight and length for gestational age.
Carrascosa A; Audí L; Fernández-Cancio M; Esteban C; Andaluz P; Vilaró E; Clemente M; Yeste D; Albisu MA; Gussinyé M
J Clin Endocrinol Metab; 2008 Mar; 93(3):764-70. PubMed ID: 18160465
[TBL] [Abstract][Full Text] [Related]
16. Exon 3-deleted genotype of growth hormone receptor (GHRd3) positively influences IGF-1 increase at generation test in children with idiopathic short stature.
Toyoshima MT; Castroneves LA; Costalonga EF; Mendonca BB; Arnhold IJ; Jorge AA
Clin Endocrinol (Oxf); 2007 Oct; 67(4):500-4. PubMed ID: 17555512
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
